TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33721986

Group type: EXPERIMENTAL
Intervention: High-speed power training
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Low-speed strength training
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (static stretching)
Number of subjects: 45
Study: 34538087

Group type: EXPERIMENTAL
Intervention: Monitoring group (platelet function monitoring-guided adjustment of antiplatelet therapy)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Conventional group (without monitoring and drug adjustment)
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Monitoring group
Number of subjects: 314

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 314
Study: 37257216

Group type: EXPERIMENTAL
Intervention: Prednisolone 40 mg/day for 14 days, then tapered to 10 mg for 1 month, followed by 5 mg/day for 2 months.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Prednisolone 20 mg/day for 14 days, then tapered to 5 mg for 2 months.
Number of subjects: 50
Study: 34444526

Group type: EXPERIMENTAL
Intervention: Variable-rate feedback infusion (VFIM) of fentanyl/ropivacaine, basal infusion rate adjusted by 0.5 mL/h increase and 0.3 mL/h decrease
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional fixed-rate basal infusion (CFIM) of fentanyl/ropivacaine, fixed basal infusion rate of 5 mL/h
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Variable-rate feedback infusion (VFIM)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional fixed-rate basal infusion (CFIM)
Number of subjects: 72
Study: 35265033

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 288

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 288
Study: 32109884

Group type: EXPERIMENTAL
Intervention: 2 sets of 6 repetitions of flywheel EOL half-squats
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 3 sets of 6 repetitions of flywheel EOL half-squats
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 1 set of 6 repetitions of flywheel EOL half-squats
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (no PAP)
Number of subjects: 13
Study: 33380195

Group type: EXPERIMENTAL
Intervention: Bone channelling
Number of subjects: 94

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 94
Study: 32056951

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the subcallosal cingulate (SCC)
Number of subjects: 16
Study: 35968574

Group type: EXPERIMENTAL
Intervention: Combined ACL and ALL reconstruction (Group II)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Isolated ACL reconstruction (Group I)
Number of subjects: 58
Study: 33479112

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 0
Study: 35064721

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 3119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3119

Group type: COMPARATOR
Intervention: Higher UA (≥6.8 mg/dl)
Number of subjects: 3119
Study: 34198658

Group type: EXPERIMENTAL
Intervention: Experimental group (habit formation techniques)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 13
Study: 616037861

Group type: EXPERIMENTAL
Intervention: Distance visual acuity
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Near visual acuity
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Interocular visual acuity difference
Number of subjects: 85
Study: 35675470

Group type: EXPERIMENTAL
Intervention: Enzalutamide plus ADT
Number of subjects: 1150

Group type: COMPARATOR
Intervention: Placebo plus ADT
Number of subjects: 1150
Study: 34782796

Group type: EXPERIMENTAL
Intervention: Diprophos (betamethasone)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Depomedrone (methylprednisolone)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Ozone
Number of subjects: 150

Group type: COMPARATOR
Intervention: Diprophos vs Depomedrone
Number of subjects: 150

Group type: COMPARATOR
Intervention: Diprophos vs Ozone
Number of subjects: 150

Group type: COMPARATOR
Intervention: Ozone vs Spondylolisthesis and Disc Herniation
Number of subjects: 150
Study: 34343214

Group type: EXPERIMENTAL
Intervention: MACC1 expression in patients with lymphatic metastasis
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: MACC1 expression in middle-aged group with lymphatic metastasis
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: MACC1 level higher than 1.4 in middle-aged group
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: MACC1 expression in 64-75 age group
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: MACC1 expression in populations younger than 64 or older than 75
Number of subjects: 297
Study: 36183135

Group type: EXPERIMENTAL
Intervention: Responsive Parenting (RP) intervention
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 194
Study: 34020509

Group type: EXPERIMENTAL
Intervention: GSK2646264 (0.5% or 1% ww)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: GSK2646264 (1%)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 32234755

Group type: EXPERIMENTAL
Intervention: AZD9496 250 mg twice daily for 5-14 days
Number of subjects: 46

Group type: COMPARATOR
Intervention: Fulvestrant 500 mg on day 1
Number of subjects: 46
Study: 35521825

Group type: EXPERIMENTAL
Intervention: 24‐h meals service
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Protein‐rich meal service
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Rehabilitation meal service
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 76
Study: 33428686

Group type: EXPERIMENTAL
Intervention: 0.05% cyclosporine A (CsA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.5% carboxymethyl cellulose (CMC)
Number of subjects: 50
Study: 34322079

Group type: EXPERIMENTAL
Intervention: PSI combined with DSA-guided monitoring (intervention group, n = 127)
Number of subjects: 255

Group type: COMPARATOR
Intervention: Standard group (PSI monitoring, n = 128)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 255
Study: 33158822

Group type: EXPERIMENTAL
Intervention: Vitamin D 3 supplementation (1600 or 800 IU/day for 2 years)
Number of subjects: 2590

Group type: COMPARATOR
Intervention: Regular follow-up
Number of subjects: 2590
Study: 34303843

Group type: EXPERIMENTAL
Intervention: Open testing policies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized testing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normalizing counts by testing rate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-pharmaceutical interventions
Number of subjects: 0
Study: 32441875

Group type: EXPERIMENTAL
Intervention: Home-based intervention to improve maternal and child outcomes
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 112
Study: 35227399

Group type: EXPERIMENTAL
Intervention: COS‐P (Circle of Security‐Parenting Intervention)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 85
Study: 32751219

Group type: EXPERIMENTAL
Intervention: High polyphenol olive oil (HPOO) - 60 mL/day (360 mg/kg polyphenols)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low polyphenol olive oil (LPOO) - 60 mL/day (86 mg/kg polyphenols)
Number of subjects: 50
Study: 35172560

Group type: EXPERIMENTAL
Intervention: Rituximab maintenance (RM)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 240
Study: 33576820

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (8000 mg)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Zinc gluconate (50 mg)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Both ascorbic acid and zinc gluconate
Number of subjects: 214

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 214
Study: 35194193

Group type: EXPERIMENTAL
Intervention: Anthracycline/cyclophosphamide‐taxane‐containing chemotherapy (AC‐T)
Number of subjects: 5924

Group type: COMPARATOR
Intervention: Docetaxel/cyclophosphamide (TC6)
Number of subjects: 5924
Study: 34146473

Group type: EXPERIMENTAL
Intervention: Killed whole-cell oral cholera vaccine (OCV)
Number of subjects: 268896

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 268896
Study: 32195655

Group type: EXPERIMENTAL
Intervention: Postdischarge home nurse visit
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard discharge
Number of subjects: 33
Study: 35079918

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) with red (λ 660 nm) and infra-red laser therapy (λ 808 nm) applied immediately and 3 and 7 days after surgery.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control side (no irradiation).
Number of subjects: 20
Study: 33314251

Group type: EXPERIMENTAL
Intervention: Marginalizing estimates of conditional odds ratios
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marginalizing estimates of conditional hazard ratios
Number of subjects: 0
Study: 35538398

Group type: EXPERIMENTAL
Intervention: ADT + D + metformin (n=39)
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: ADT + D (n=357)
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: ADT + metformin (n=29)
Number of subjects: 788

Group type: COMPARATOR
Intervention: ADT alone (n=363)
Number of subjects: 788
Study: 33637085

Group type: EXPERIMENTAL
Intervention: Cryoneurolysis + standardized education and exercise (CRYO)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Sham + standardized education and exercise (SHAM)
Number of subjects: 94
Study: 33814250

Group type: EXPERIMENTAL
Intervention: Cancellous bone only (C-only)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Corticocancellous (CC) grafting
Number of subjects: 98
Study: 33228757

Group type: EXPERIMENTAL
Intervention: Cash transfer intervention
Number of subjects: 1984

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 1984
Study: 32538252

Group type: EXPERIMENTAL
Intervention: MDMA (100 mg MDMA-HCl)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (100 mg ascorbic acid)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: MDMA
Number of subjects: 25
Study: 33080378

Group type: EXPERIMENTAL
Intervention: Mindfulness-based relapse prevention (MBRP) group intervention
Number of subjects: 240

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) control group
Number of subjects: 240
Study: 34666854

Group type: EXPERIMENTAL
Intervention: CGMP (20 g)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CGMP (40 g)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CGMP (60 g)
Number of subjects: 15
Study: 34024503

Group type: EXPERIMENTAL
Intervention: Ketone monoester supplement
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 33046053

Group type: EXPERIMENTAL
Intervention: High-dose corticosteroid therapy (5-day standard treatment)
Number of subjects: 318

Group type: COMPARATOR
Intervention: Low-dose corticosteroid therapy (eosinophil-guided intervention)
Number of subjects: 318
Study: 34991417

Group type: EXPERIMENTAL
Intervention: Jump technique
Number of subjects: 130

Group type: COMPARATOR
Intervention: Seton technique
Number of subjects: 130
Study: 33515770

Group type: EXPERIMENTAL
Intervention: MRI screening (annual MRI and biennial mammography)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Mammography screening (annual mammography)
Number of subjects: 412
Study: 34793361

Group type: EXPERIMENTAL
Intervention: Low-volume HIIT (2 d/wk)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: High-volume HIIT (2 d/wk)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Attention Control (AC) (physical activity recommendations)
Number of subjects: 70
Study: 32920297

Group type: EXPERIMENTAL
Intervention: High-fat meals (67 E% fat)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low-fat meals (16 E% fat)
Number of subjects: 20
Study: 35818238

Group type: EXPERIMENTAL
Intervention: Ultra-mini percutaneous nephrolithotomy combined with ShuoTong ureteroscopy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ultra-mini percutaneous nephrolithotomy
Number of subjects: 42
Study: 34498056

Group type: EXPERIMENTAL
Intervention: Filgotinib (FIL) 200 mg once daily for 12 weeks
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Lanraplenib (LANRA) 30 mg once daily for 12 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (PBO) once daily for 12 weeks
Number of subjects: 47
Study: 35130320

Group type: EXPERIMENTAL
Intervention: Shared Medical Appointments (SMAs)
Number of subjects: 24
Study: 34836025

Group type: EXPERIMENTAL
Intervention: Tocovid (200 mg twice daily)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 32708511

Group type: EXPERIMENTAL
Intervention: KW3110
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 36267362

Group type: EXPERIMENTAL
Intervention: CONT-MMI (continuation of low-dose methimazole therapy at 2.5-5 mg/day)
Number of subjects: 184

Group type: COMPARATOR
Intervention: DISCONT-MMI (discontinuation of low-dose methimazole therapy)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: CONT-MMI
Number of subjects: 184

Group type: COMPARATOR
Intervention: DISCONT-MMI
Number of subjects: 184
Study: 35793833

Group type: EXPERIMENTAL
Intervention: Lenzilumab (1800 mg; three divided doses, q8h, within 24 hours)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520
Study: 33359752

Group type: EXPERIMENTAL
Intervention: Known diabetes receiving metformin
Number of subjects: 4393

Group type: EXPERIMENTAL
Intervention: Pre-diabetes
Number of subjects: 4393
Study: 35964207

Group type: EXPERIMENTAL
Intervention: Treadmill training with visual feedback and rhythmic auditory cue (VF+RAC)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (treadmill training without visual and auditory stimulation)
Number of subjects: 32
Study: 33957195

Group type: EXPERIMENTAL
Intervention: 0.75% Ruxolitinib cream
Number of subjects: 1249

Group type: EXPERIMENTAL
Intervention: 1.5% Ruxolitinib cream
Number of subjects: 1249

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 1249
Study: 36223695

Group type: EXPERIMENTAL
Intervention: Subcutaneous trastuzumab into the thigh
Number of subjects: 219

Group type: COMPARATOR
Intervention: Subcutaneous trastuzumab into the abdominal wall (AW)
Number of subjects: 219
Study: 34170392

Group type: EXPERIMENTAL
Intervention: Resistant dextrin (14 g/day NUTRIOSE® FB06)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Maltodextrin control
Number of subjects: 36
Study: 32630031

Group type: EXPERIMENTAL
Intervention: Traditional therapy (5‐methyl‐tetrahydrofolate: 15 mg/day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 5 mL/day of Oxo with 300 μg folic acid (oxifolic)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 5 mL/day of Oxo alone (magnesio+)
Number of subjects: 32
Study: 36141878

Group type: EXPERIMENTAL
Intervention: Pasos Para Prevenir Cancer (PPPC) program
Number of subjects: 209
Study: 33821693

Group type: EXPERIMENTAL
Intervention: 300 mg intravenous Q4W
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: 300 mg subcutaneous Q4W
Number of subjects: 290

Group type: COMPARATOR
Intervention: 300 mg intravenous Q12W
Number of subjects: 290

Group type: COMPARATOR
Intervention: 300 mg subcutaneous Q12W
Number of subjects: 290

Group type: COMPARATOR
Intervention: 150 mg intravenous Q12W
Number of subjects: 290

Group type: COMPARATOR
Intervention: 150 mg subcutaneous Q12W
Number of subjects: 290
Study: 32584979

Group type: EXPERIMENTAL
Intervention: SCORE screening (10-year fatal and non-fatal risk)
Number of subjects: 14478

Group type: COMPARATOR
Intervention: CAC scoring
Number of subjects: 14478
Study: 35907900

Group type: EXPERIMENTAL
Intervention: ADVANCE digital intervention (comprising a preparatory one‐to‐one session, six fortnightly online group sessions, and 12 weekly self‐directed website sessions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ADVANCE digital intervention
Number of subjects: 60
Study: 34609773

Group type: EXPERIMENTAL
Intervention: Depatuxizumab mafodotin plus chemotherapy (temozolomide) in second-line therapy for EGFR-amplified recurrent WHO grade III/IV glioma
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Depatuxizumab mafodotin alone in second-line therapy for EGFR-amplified recurrent WHO grade III/IV glioma
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Depatuxizumab mafodotin plus chemoradiotherapy in first-line therapy for newly diagnosed WHO grade III/IV glioma
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Depatuxizumab mafodotin alone or plus chemotherapy/chemoradiotherapy
Number of subjects: 53
Study: 34144507

Group type: EXPERIMENTAL
Intervention: Positive affect intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Contingency management (CM)
Number of subjects: 110
Study: 32028023

Group type: EXPERIMENTAL
Intervention: Topical 5% minoxidil gel
Number of subjects: 62

Group type: COMPARATOR
Intervention: Topical 0.2% glyceryl trinitrate (GTN) cream
Number of subjects: 62
Study: 34231044

Group type: EXPERIMENTAL
Intervention: Metaphyseal anchoring short stem
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Shortened straight stem
Number of subjects: 18

Group type: COMPARATOR
Intervention: Straight stem
Number of subjects: 18
Study: 34058422

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 342
Study: 75134022

Group type: EXPERIMENTAL
Intervention: Feedback assisted deep muscle relaxation training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention placebo
Number of subjects: 0
Study: 34455583

Group type: EXPERIMENTAL
Intervention: Bamlanivimab (700 mg, 2,800 mg, or 7,000 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32843370

Group type: EXPERIMENTAL
Intervention: Pasireotide long-acting release
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 34971025

Group type: EXPERIMENTAL
Intervention: Coach Pepper (humanoid SAR system)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Tablet PC-based dementia training (control)
Number of subjects: 32
Study: 33002745

Group type: EXPERIMENTAL
Intervention: Virtual simulator
Number of subjects: 60

Group type: COMPARATOR
Intervention: Video-assisted teaching
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 60
Study: 33782504

Group type: EXPERIMENTAL
Intervention: Chronic whole-body cryotherapy (10 sessions, 3-min at -110 °C)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Chronic whole-body cryotherapy
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Single session of whole-body cryotherapy
Number of subjects: 35
Study: 32535135

Group type: COMPARATOR
Intervention: Baked Egg (BE) therapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Egg Oral Immunotherapy (OIT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Baked Egg (BE) therapy (comparator group)
Number of subjects: 50
Study: 34836662

Group type: EXPERIMENTAL
Intervention: Susceptibility-guided therapy (SGT) with gastric juice PCR
Number of subjects: 182

Group type: COMPARATOR
Intervention: Clarithromycin-based standard triple therapy (STT)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Susceptibility-guided therapy (SGT)
Number of subjects: 182
Study: 32583392

Group type: EXPERIMENTAL
Intervention: Fine-needle biopsy (FNB)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fine-needle aspiration (FNA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Forward-facing bevel FNB needles
Number of subjects: 18

Group type: COMPARATOR
Intervention: Reverse bevel FNB needle
Number of subjects: 18
Study: 34893487

Group type: EXPERIMENTAL
Intervention: Decision aid only
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Decision aid with VCM
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (no decision aid)
Number of subjects: 35
Study: 32382114

Group type: EXPERIMENTAL
Intervention: Hydrocortisone treatment
Number of subjects: 48

Group type: COMPARATOR
Intervention: Rescue dexamethasone after hydrocortisone therapy
Number of subjects: 48
Study: 36147331

Group type: EXPERIMENTAL
Intervention: Oral cannabis (0, 10, or 25 mg Δ9‐THC)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Vaporized cannabis (0, 10, or 25 mg Δ9‐THC)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Alcohol (target BAC of 0.05%)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Alcohol (target BAC of 0.08%)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo cannabis
Number of subjects: 32
Study: 32931024

Group type: EXPERIMENTAL
Intervention: Hyperthermic intraperitoneal chemotherapy (HIPEC) after interval debulking surgery (IDS)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no HIPEC)
Number of subjects: 200
Study: 33555943

Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Concentric training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 26
Study: 36083855

Group type: EXPERIMENTAL
Intervention: Leukotriene receptor antagonists (LTRA), specifically 10 mg of montelukast orally daily for 8 weeks.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Observation group (control).
Number of subjects: 40
Study: 33284719

Group type: EXPERIMENTAL
Intervention: Mefenpyr‐diethyl (50 g a.i. ha‐1) applied on soybean plants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32249668

Group type: EXPERIMENTAL
Intervention: Agility Boot Camp‐Cognitive (ABC‐C)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Education interventions
Number of subjects: 46
Study: 36050815

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg once daily for 6 months
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1500
Study: 36219918

Group type: EXPERIMENTAL
Intervention: Electromyographic-biofeedback-assisted pelvic floor muscle training (BAPFMT) combined with neuromuscular electrical stimulation (NMES) of the rectus abdominis
Number of subjects: 66

Group type: COMPARATOR
Intervention: Neuromuscular electrical stimulation (NMES) of the rectus abdominis alone
Number of subjects: 66
Study: 32277701

Group type: EXPERIMENTAL
Intervention: Factory‐impregnated permethrin clothing
Number of subjects: 82

Group type: COMPARATOR
Intervention: Sham‐treated clothing
Number of subjects: 82
Study: 33130463

Group type: EXPERIMENTAL
Intervention: CATCH My Breath Program (CMB)
Number of subjects: 1400000